Open AccessThe efficacy and safety of romiplostim in the treatment of thrombocytopenia in pediatric patients with Wiskott–Aldrich syndrome: the results of a retrospective study
Author(s) -
А. Л. Хорева,
Irina Abramova,
Elena Deripapa,
Ю. А. Родина,
А. А. Роппельт,
V.I. Burlakov,
Dmitriy Pershin,
Sergey S. Larin,
Е. В. Райкина,
Т. В. Варламова,
А. М. Киева,
К. А. Воронин,
Alexey Maschan,
Galiovichkova,
Anna Shcherbina
Publication year - 2021
Publication title -
voprosy gematologii/onkologii i immunopatologii v pediatrii
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.108
H-Index - 3
eISSN - 2414-9314
pISSN - 1726-1708
DOI - 10.24287/1726-1708-2020-19-4suppl-39-49
Subject(s) - romiplostim , medicine , hematology , wiskott–aldrich syndrome , thrombopoietin receptor , adverse effect , thrombopoietin , stem cell , haematopoiesis , biochemistry , chemistry , genetics , gene , biology